Litcius/Paper detail

Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial

Gregory M. Marcus, Roderick Tung, Edward P. Gerstenfeld, Trisha F. Hue, Feng Lin, Jing Cheng, J. Peter Weiss, Wendy S. Tzou, Henry H. Hsia, Ashkan Ehdaie, Daniel H. Cooper, T. Jared Bunch, Jeffrey Arkles, Babak Nazer, Adam Lee, Alexios Hadjis, Duy T. Nguyen, Mihail G. Chelu, Joshua D. Moss, Jonathan C. Hsu, Miguel Valderrábano, Prashant D. Bhave, Andrew D. Beaser, Arvindh N. Kanagasundram, Oussama M. Wazni, Jason S. Bradfield, Grace Wall, Kathleen Chang, Michelle Yang, Gabrielle Montenegro, Sabrina Jarrott, Joel H. Kramer, Anthony Kim, Yonca Morris, W.P. Dillon

2025Circulation14 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Catheter ablation of ventricular arrhythmias, one of the most rapidly growing procedures in cardiac electrophysiology, is associated with magnetic resonance imaging-detected brain lesions in more than half of cases. Although a retrograde aortic approach is conventional, modern tools enable entry through a transseptal approach that may avoid embolization of debris from the arterial system. We sought to test the hypothesis that a transseptal puncture would mitigate brain injury compared with a retrograde aortic approach. METHODS: The TRAVERSE trial (Transseptal Versus Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli) was a multicenter randomized controlled comparative effectiveness trial. Patients with left ventricular arrhythmias undergoing catheter ablation procedures were randomly assigned to a transseptal puncture approach compared (1:1) with a retrograde aortic approach. The primary outcome was the presence of an acute brain lesion detected by magnetic resonance imaging. Secondary outcomes included clinically manifest complications, procedural efficacy, and 6-month neurocognitive assessments. RESULTS: =0.036). No differences in clinically manifest complications or procedural efficacy were observed. More patients in the retrograde aortic arm were categorized as having a high likelihood of cognitive impairment at 6 months (33% compared with 19% of those in the transseptal arm), but substantial loss to follow-up was present. CONCLUSIONS: Among patients undergoing left ventricular catheter ablation procedures, a transseptal approach reduced the risk of acute brain lesions by nearly half compared with a retrograde aortic approach without sacrificing safety or efficacy. Given a likely embolic pathogenesis, the brain magnetic resonance imaging findings may reflect a propensity to other organ damage; these findings may extend to other procedures requiring left ventricular entry. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03946072.

Topics & Concepts

MedicineMagnetic resonance imagingAblationCardiologyCatheter ablationCatheterRandomized controlled trialRadiologyInternal medicineSurgeryAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac Valve Diseases and Treatments
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized Trial | Litcius